South America Pancreatic Cancer Therapeutics and Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)

The South American Pancreatic Cancer Therapeutics and Diagnostics Market is Segmented by Type (Treatment and Diagnostics) and Geography

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

CAGR:

5.8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The market studied is majorly driven by factors, such as the increasing prevalence of pancreatic cancer and the increasing demand for diagnostic tests and treatments of this disease. As a result, many governments and non-profit organizations have taken initiatives to spread awareness regarding pancreatic cancer in the South American region.

Moreover, the technological advancements in diagnostics and treatments have have led to solutions that are more efficient. Hence, all these are the major factors that have propelled the growth of the market.

Scope of the report

As per the scope of the report, pancreatic cancer happens when uncontrolled cell growth begins in a part of the pancreas. Tumors develop, and these interfere with the way the pancreas works. pancreatic cancer therapeutics and diagnostics involve procedures for successful diagnosis and treatment of pancreatic cancer.

By Type
By Treatment
Surgery
Chemotherapy
Targeted Therapy
Other Treatments
By Diagnostics
Imaging
Biopsy
Endoscopy
Other Diagnostics
Geography
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Chemotherapy Segment is Expected to Cover a Large Share of the Pancreatic Cancer Therapeutics & Diagnostics Market

Chemotherapy is the use of drugs to destroy cancer cells, usually by ending the cancer cells ability to grow and divide. A chemotherapy regimen, or schedule, usually consists of a specific number of cycles given over a set period of time. There is usually a rest period in between cycles. A patient may receive 1 drug at a time or a combination of different drugs given at the same time. Chemotherapy thus is an important part of multimodality pancreatic cancer treatment. After curative resection, adjuvant chemotherapy can significantly improve disease-free survival and overall survival. Therefore this will increase the demand for chemotherapy therapy in future, which is expected to help the market growth.

To understand key trends, Download Sample Report

Competitive Landscape

South America is a developing region. Although the healthcare system in many countries in the region are not highly developed, these countries are spending more each year in their healthcare system. This has encouraged many global companies to enter the market and as a result, many global players in the pancreatic cancer therapeutics and diagnostics market are present in the region. These factors have made the region very competitive.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidence and Prevalence of Pancreatic Cancer

      2. 4.2.2 Technological Advancements and Innovation of New Products

    3. 4.3 Market Restraints

      1. 4.3.1 High Costs Associated with Treatment and Diagnosis

      2. 4.3.2 Drug Toxicity and Side Effects

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 By Treatment

        1. 5.1.1.1 Surgery

        2. 5.1.1.2 Chemotherapy

        3. 5.1.1.3 Targeted Therapy

        4. 5.1.1.4 Other Treatments

      2. 5.1.2 By Diagnostics

        1. 5.1.2.1 Imaging

        2. 5.1.2.2 Biopsy

        3. 5.1.2.3 Endoscopy

        4. 5.1.2.4 Other Diagnostics

    2. 5.2 Geography

      1. 5.2.1 South America

        1. 5.2.1.1 Brazil

        2. 5.2.1.2 Argentina

        3. 5.2.1.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bristol-Myers Squibb

      2. 6.1.2 Canon Medical Systems

      3. 6.1.3 Eli Lilly and Company

      4. 6.1.4 F. Hoffmann-La Roche AG

      5. 6.1.5 GE Healthcare

      6. 6.1.6 Hitachi Medical

      7. 6.1.7 Novartis AG

      8. 6.1.8 Pfizer Inc

      9. 6.1.9 Philips Healthcare

      10. 6.1.10 Siemens AG

  7. *List Not Exhaustive
  8. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports